tradingkey.logo

Moderna Announces Positive Phase 3 Results For Seasonal Influenza Vaccine

ReutersJun 30, 2025 11:35 AM

- Moderna Inc MRNA.O:

  • MODERNA - ANNOUNCES POSITIVE PHASE 3 RESULTS FOR SEASONAL INFLUENZA VACCINE

  • MODERNA - MRNA-1010 ACHIEVED STRINGENT SUPERIORITY CRITERION PRESPECIFIED IN THE PROTOCOL, WITH AN RVE OF 26.6% IN OVERALL STUDY POPULATION

  • MODERNA - IN PARTICIPANTS AGED 65 YEARS AND OLDER, MRNA-1010 DEMONSTRATED AN RVE OF 27.4%

  • MODERNA - SAFETY AND TOLERABILITY OF MRNA-1010 WERE CONSISTENT WITH REPORTED RESULTS FROM A PREVIOUS PHASE 3 STUDY.

  • MODERNA - STRONG RVE WAS OBSERVED FOR EACH INFLUENZA STRAIN CONTAINED IN THE VACCINE DURING STUDY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI